Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Paul Goh"'
Autor:
Tazeen H. Jafar, Ngiap Chuan Tan, John C. Allen, Eric A. Finkelstein, Paul Goh, Peter Moey, Joanne Hui Min Quah, Siew Wai Hwang, Juliana Bahadin, Anandan Gerard Thiagarajah, Jason Chan, Gary Kang, Agnes Koong
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-12 (2018)
Abstract Background Hypertension is a serious public health problem in Singapore and is associated with significant morbidity and mortality from cardiovascular disease (CVD) with considerable implications for health-care resources. The goal of the tr
Externí odkaz:
https://doaj.org/article/de81f3f02a004ba19cb77a0b63ef5356
Autor:
Zhen Sinead Wang, N Nivedita, Khung Keong Yeo, Jonathan Yap, Shaw Yang Chia, Matthew Seow, Ngiap Chuan Tan, Teck Wee Andrew Ang, Yi Ling Eileen Koh, Siang Jin Terrance Chua, Cia Sin Lee, Lee Lim Joanna Tan, Soo Chye Paul Goh, Chai Wah Ooi
Publikováno v:
J Gen Intern Med
BACKGROUND: Coronary artery disease (CAD) risk prediction tools are useful decision supports. Their clinical impact has not been evaluated amongst Asians in primary care. OBJECTIVE: We aimed to develop and validate a diagnostic prediction model for C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::531bfb9c6e3129b979615c2cd094af3e
https://europepmc.org/articles/PMC8175488/
https://europepmc.org/articles/PMC8175488/
Publikováno v:
Singapore Med J
Introduction Hypertension and dyslipidaemia are major risk factors for cardiovascular diseases and achieving treatment goals mitigates such risks. This study determined demographic and medication-related factors associated with blood pressure (BP) go
Publikováno v:
Proceedings of Singapore Healthcare, Vol 26 (2017)
Background: Men differ from women in their cardiovascular mortality and morbidity globally, possibly due to their varying dietary and lifestyle behavior and usage of medications in dyslipidemia control. Objectives: The study aimed to compare the gend
Autor:
Kim Hwee Koh, Chin Chin Goh, Soo Chye Paul Goh, Yi Ling Eileen Koh, Ngiap Chuan Tan, Koh, Kim Hwee, Goh, Chin Chin, Goh, Soo Chye Paul, Koh, Yi Ling Eileen, Tan, Ngiap Chuan
Publikováno v:
Singapore Medical Journal; Sep2020, Vol. 61 Issue 9, p469-475, 7p
Publikováno v:
Journal of clinical pharmacy and therapeutics. 41(6)
SummaryWhat is known and objective Dyslipidaemia is the key risk factor for arthrosclerosis, leading to myocardial infarctions and strokes. Achieving LDL cholesterol (LDL-C) treatment goals using lipid-lowering therapy (LLT) mitigates such cardiovasc
Autor:
Chow Wai Leng, Veena D Joshi, Paul Goh Soo Chye, Swah Teck Sin, Stephanie Teo Swee Hong, Saskia van der Erf, Ow Yong Lai Meng, Terence Kee Yi-Shern, Crystal Lim, Gilbert Tan Choon Seng
Publikováno v:
Progress in Transplantation. 22:95-101
Context— Kidney transplantation is the best treatment option for kidney failure, but the supply of donor kidneys remains small. Objective— To understand the public's attitude toward living donor kidney donation in Singapore. Design, Setting and P
Publikováno v:
Journal of clinical lipidology. 10(2)
Dyslipidemia is the primary risk factor for arthrosclerosis. It is the most common chronic disease among the multiethnic Asian population in Singapore. Local national health survey has shown ethnic variability in achieving control of dyslipidemia.Thi
Autor:
Kong Boo Phua, Seng Hock Quak, Fong Seng Lim, Paul Goh, Yee Leong Teoh, Sanjoy Kumar Datta, Htay Htay Han, Hans Ludwig Bock
Publikováno v:
Annals of the Academy of Medicine, Singapore. 37:546-553
Introduction: In recent years, acellular pertussis combination vaccines have facilitated compliance with and coverage of the national immunisation programme in Singapore. This phase-II study (Rota-007) evaluated the immunogenicity, reactogenicity and
Autor:
Paul Goh, Emmanuel Sc, Htay Htay Han, Kong Boo Phua, H.L. Bock, Bee Wah Lee, Beatrice De Vos, Seng Hock Quak
Publikováno v:
The Journal of Infectious Diseases. 192:S6-S16
Background At present, no rotavirus vaccine is commercially available for use worldwide. Hence, a live, attenuated monovalent vaccine was developed with human strain RIX4414 (G1P1A P[8] specificity). Vaccination trials involving infants are ongoing i